| Authors: |
Petersenn S; ENDOC Center for Endocrine Tumors, Hamburg, Germany. stephan.petersenn@endoc-med.de., Salgado LR; Division of General Internal Medicine, Hospital das Clínicas, University of São Paulo Medical School, São Paulo, Brazil., Schopohl J; Medizinische Klinik IV, University of Munich, Munich, Germany., Portocarrero-Ortiz L; Department of Neuroendocrinology, National Institute of Neurology and Neurosurgery, Mexico City, Mexico., Arnaldi G; Division of Endocrinology, Polytechnic University of Marche Region, Ancona, Italy., Lacroix A; Division of Endocrinology, Centre hospitalier de l'Université de Montréal, Montreal, Canada., Scaroni C; Endocrinology Unit, Department of Medicine, Padova University Hospital, Padova, Italy., Ravichandran S; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Kandra A; Novartis Pharma AG, Basel, Switzerland., Biller BMK; Neuroendocrine Clinical Center, Massachusetts General Hospital, Boston, MA, USA. |
